Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 14, 2025 • 4:30 AM ET

Date/Time Source News Release
05/08/2025 04:05 PM EDT PR Newswire Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates
05/06/2025 10:58 AM EDT PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of Shareholders
05/01/2025 12:49 PM EDT PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, SWTX on Behalf of Shareholders
04/30/2025 09:00 AM EDT Business Wire RGLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Regulus Therapeutics Inc. Is Fair to Shareholders
04/30/2025 07:00 AM EDT PR Newswire Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG
04/02/2025 08:00 AM EDT PR Newswire Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit
03/27/2025 07:00 AM EDT PR Newswire Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
03/13/2025 04:05 PM EDT PR Newswire Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates
03/04/2025 08:00 AM EST PR Newswire Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference
02/04/2025 08:00 AM EST PR Newswire Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Page

Additional News

As of May 14, 2025 • 4:30 AM ET

Date/Time Source News Release
05/10/2025 11:00 AM EDT SeekingAlpha Cisco, Walmart Set To Report Results As Markets Watch Out For Core CPI
05/09/2025 03:00 PM EDT SeekingAlpha Catalyst Watch: China trade talks, Walmart earnings, and Take-Two on the GTA hot seat
05/08/2025 05:28 PM EDT SeekingAlpha Regulus Therapeutics GAAP EPS of -$0.15 beats by $0.09
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Regulus Therapeutics Inc.
05/03/2025 03:15 PM EDT SeekingAlpha Key deals this week: Gold Fields, Palo Alto, Novartis, LendingClub and more
05/01/2025 11:02 AM EDT SeekingAlpha Regulus CVR may be worth $3-$4 a share in Novartis deal - analyst
04/30/2025 04:30 PM EDT SeekingAlpha Regulus Therapeutics Acquisition By Novartis Due To Key Farabursen Advancements
04/30/2025 08:55 AM EDT AllPennyStocks.com Biotech Stock Soars Over 100% On Premarket Following Acquisition Announcement
04/30/2025 07:19 AM EDT SeekingAlpha Novartis to acquire Regulus for $7.00 a share in cash
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.